Literature DB >> 22633193

Expression of CCR7 and CD45RA in CD4+ and CD8+ subsets in cerebrospinal fluid of 134 patients with inflammatory and non-inflammatory neurological diseases.

Katherine M Mullen1, Anne R Gocke, Rameeza Allie, Achilles Ntranos, Inna V Grishkan, Carlos Pardo, Peter A Calabresi.   

Abstract

We investigated CD45RA and CCR7 expression in CD4+ and CD8+ subsets of cerebrospinal fluid (CSF) lymphocytes, both immediately ex vivo and after stimulation, from 134 patients with a variety of inflammatory and non-inflammatory neurological diseases. Most inflammatory diseases had a higher CD4+:CD8+ ratio and higher percentage of effector memory T cells (T(EM)) than non-inflammatory controls, excluding active infection. Moreover, we found that patients with highly elevated cell counts in the CSF tended to have a lower percentage of central memory T cells (T(CM)) than patients with low or absent pleocytosis, with a concomitant increase in T(EM). We also found that samples with elevated IgG index or presence of oligoclonal bands had a significantly higher CD4+:CD8+ ratio than normal samples, consistent with increased CD4+ help for intrathecal IgG synthesis by B cells.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633193      PMCID: PMC3391349          DOI: 10.1016/j.jneuroim.2012.04.017

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  22 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.

Authors:  Debora Giunti; Giovanna Borsellino; Roberto Benelli; Monica Marchese; Elisabetta Capello; Maria Teresa Valle; Enrico Pedemonte; Douglas Noonan; Adriana Albini; Giorgio Bernardi; Giovanni Luigi Mancardi; Luca Battistini; Antonio Uccelli
Journal:  J Leukoc Biol       Date:  2003-05       Impact factor: 4.962

3.  Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis.

Authors:  Eckhart Sindern; Tanja Patzold; Ludgera Manuela Ossege; Astrid Gisevius; Jean Pierre Malin
Journal:  J Neuroimmunol       Date:  2002-10       Impact factor: 3.478

4.  Soluble and cell surface ICAM-3 in blood and cerebrospinal fluid of patients with multiple sclerosis: influence of methylprednisolone treatment and relevance as markers for disease activity.

Authors:  J Kraus; P Oschmann; B Engelhardt; R Bauer; C Schiel; A Kern; E Stolz; A Traupe; W Dorndorf
Journal:  Acta Neurol Scand       Date:  2000-02       Impact factor: 3.209

5.  The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.

Authors:  Horea Rus; Carlos A Pardo; Lina Hu; Erika Darrah; Cornelia Cudrici; Teodora Niculescu; Florin Niculescu; Katharine M Mullen; Rameeza Allie; Liping Guo; Heike Wulff; Christine Beeton; Susan I V Judge; Douglas A Kerr; Hans-Gunther Knaus; K George Chandy; Peter A Calabresi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

6.  T-cell subsets in the cerebrospinal fluid and blood of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neuroimmunol       Date:  1988-12       Impact factor: 3.478

7.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

Authors:  T Olsson; W W Zhi; B Höjeberg; V Kostulas; Y P Jiang; G Anderson; H P Ekre; H Link
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

8.  CD45RA+ ICAM-3+ lymphocytes in cerebrospinal fluid and blood as markers of disease activity in patients with multiple sclerosis.

Authors:  J Kraus; P Oschmann; B Engelhardt; E Stolz; B S Kuehne; C Laske; C Schaefer; H Traupe; M Kaps
Journal:  Acta Neurol Scand       Date:  2000-11       Impact factor: 3.209

9.  Expression of CCR7 in multiple sclerosis: implications for CNS immunity.

Authors:  Pia Kivisäkk; Don J Mahad; Melissa K Callahan; Keith Sikora; Corinna Trebst; Barbara Tucky; Jerome Wujek; Rivka Ravid; Susan M Staugaitis; Hans Lassmann; Richard M Ransohoff
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

10.  The imbalance in CSF T cell subsets in active multiple sclerosis.

Authors:  M Matsui; K J Mori; T Saida; I Akiguchi; M Kameyama
Journal:  Acta Neurol Scand       Date:  1988-03       Impact factor: 3.209

View more
  12 in total

Review 1.  Novel therapies for memory cells in autoimmune diseases.

Authors:  P Bhargava; P A Calabresi
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

2.  High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  A Harrer; G Pilz; P Wipfler; K Oppermann; J Sellner; W Hitzl; E Haschke-Becher; S Afazel; T Rispens; D van der Kleij; E Trinka; J Kraus
Journal:  Clin Exp Immunol       Date:  2015-04-27       Impact factor: 4.330

3.  Analysis of CD4+ CD8+ double-positive T cells in blood, cerebrospinal fluid and multiple sclerosis lesions.

Authors:  A Waschbisch; L Sammet; S Schröder; D-H Lee; A Barrantes-Freer; C Stadelmann; R A Linker
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

4.  Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model.

Authors:  Sam R Adhikary; Peter Cuthbertson; Leigh Nicholson; Katrina M Bird; Chloe Sligar; Min Hu; Philip J O'Connell; Ronald Sluyter; Stephen I Alexander; Debbie Watson
Journal:  Immunology       Date:  2021-06-13       Impact factor: 7.215

5.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research.

Authors:  Kenneth W Witwer; Edit I Buzás; Lynne T Bemis; Adriana Bora; Cecilia Lässer; Jan Lötvall; Esther N Nolte-'t Hoen; Melissa G Piper; Sarada Sivaraman; Johan Skog; Clotilde Théry; Marca H Wauben; Fred Hochberg
Journal:  J Extracell Vesicles       Date:  2013-05-27

6.  In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.

Authors:  Sreeja Varghese; Michelle Cotter; Franciane Chevot; Claire Fergus; Colm Cunningham; Kingston H Mills; Stephen J Connon; John M Southern; Vincent P Kelly
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

Review 7.  Mesenchymal Stem Cells Improve Rheumatoid Arthritis Progression by Controlling Memory T Cell Response.

Authors:  Noymar Luque-Campos; Rafael A Contreras-López; María Jose Paredes-Martínez; Maria Jose Torres; Sarah Bahraoui; Mingxing Wei; Francisco Espinoza; Farida Djouad; Roberto Javier Elizondo-Vega; Patricia Luz-Crawford
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

Review 8.  Single-Cell High-Throughput Technologies in Cerebrospinal Fluid Research and Diagnostics.

Authors:  Tobias V Lanz; Anne-Katrin Pröbstel; Iris Mildenberger; Michael Platten; Lucas Schirmer
Journal:  Front Immunol       Date:  2019-06-11       Impact factor: 7.561

9.  Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping.

Authors:  Paavali A Hannikainen; Peter Kosa; Christopher Barbour; Bibiana Bielekova
Journal:  Front Neurol       Date:  2020-11-27       Impact factor: 4.003

10.  Classification of neurological diseases using multi-dimensional CSF analysis.

Authors:  Catharina C Gross; Andreas Schulte-Mecklenbeck; Lohith Madireddy; Marc Pawlitzki; Christine Strippel; Saskia Räuber; Julia Krämer; Leoni Rolfes; Tobias Ruck; Carolin Beuker; Antje Schmidt-Pogoda; Lisa Lohmann; Tilman Schneider-Hohendorf; Tim Hahn; Nicholas Schwab; Jens Minnerup; Nico Melzer; Luisa Klotz; Sven G Meuth; Gerd Meyer Zu Hörste; Sergio E Baranzini; Heinz Wiendl
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.